Displaying drugs 651 - 675 of 908 in total
(2S)-2,3-Diaminobutanoic acid
Experimental
Matched Synonyms: … L-Threo-alpha,beta-diaminobutyric acid …
Teniposide
Teniposide is a semisynthetic derivative of podophyllotoxin that exhibits antitumor activity. Teniposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent cells from entering into the mitotic...
Approved
Matched Synonyms: … 4'-demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside) …
Matched Description: … Teniposide acts primarily in the G2 and S phases of the cycle. ... Teniposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. ... This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. …
Matched Categories: … Antineoplastic and Immunomodulating Agents …
Matched Description: … Teniposide acts primarily in the G2 and S phases of the cycle. ... Teniposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. ... This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. …
Matched Categories: … Antineoplastic and Immunomodulating Agents …
Olpasiran
Olpasiran is under investigation in clinical trial NCT05581303 (Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (Ocean(a)) - Outcomes Trial).
Investigational
Matched Synonyms: … ALL-P-AMBO-5'-O-((25S,30S)-39-((2-ACETAMIDO-2-DEOXY-.BETA. ... -D-GALACTOPYRANOSYL)OXY)-25,30-BIS((2-(2-((2-ACETAMIDO-2-DEOXY-.BETA. …
Matched Description: … Olpasiran is under investigation in clinical trial NCT05581303 (Olpasiran Trials of Cardiovascular Events and …
Matched Categories: … Nucleic Acids, Nucleotides, and Nucleosides …
Matched Description: … Olpasiran is under investigation in clinical trial NCT05581303 (Olpasiran Trials of Cardiovascular Events and …
Matched Categories: … Nucleic Acids, Nucleotides, and Nucleosides …
1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose
Includes ortho-, meta-, and para-nitrophenylgalactosides. [PubChem]
Experimental
Matched Name: … 1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose …
Matched Description: … Includes ortho-, meta-, and para-nitrophenylgalactosides. [PubChem] …
Matched Description: … Includes ortho-, meta-, and para-nitrophenylgalactosides. [PubChem] …
Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate
Adenylic acid. Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2'-, 3'-, or 5'-position. [PubChem]
Experimental
Matched Name: … Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate …
Beta-1,2,3,4,6-Penta-O-Galloyl-D-Glucopyranose
Experimental
Matched Name: … Beta-1,2,3,4,6-Penta-O-Galloyl-D-Glucopyranose …
N-acetyl-N'-beta-D-glucopyranosyl urea
Experimental
Matched Name: … N-acetyl-N'-beta-D-glucopyranosyl urea …
(2s)-4-(Beta-Alanylamino)-2-Aminobutanoic Acid
Experimental
Matched Name: … (2s)-4-(Beta-Alanylamino)-2-Aminobutanoic Acid …
[4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE]
Experimental
Matched Name: … [4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE] …
PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE
Experimental
Matched Name: … PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE …
Idroxioleic acid
Investigational
Matched Synonyms: … 9-octadecenoic acid, 2-hydroxy-, (9z)- ... Rac-(2r,9z)-2-hydroxyoctadec-9-enoic acid …
Matched Iupac: … (9Z)-2-hydroxyoctadec-9-enoic acid …
Matched Iupac: … (9Z)-2-hydroxyoctadec-9-enoic acid …
Hemicellulase
Experimental
Matched Synonyms: … Endo-1,4-beta-xylanase A …
Matched Categories: … Enzymes and Coenzymes …
Matched Categories: … Enzymes and Coenzymes …
Deuruxolitinib
Deuruxolitinib is under investigation in clinical trial NCT03898479 (Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata).
Investigational
Matched Synonyms: … 1h-pyrazole-1-propanenitrile, .beta. ... -(cyclopentyl-2,2,3,3,4,4,5,5-d8)-4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-, (.beta.r)- …
Matched Description: … Deuruxolitinib is under investigation in clinical trial NCT03898479 (Extension Study to Evaluate Safety and …
Matched Description: … Deuruxolitinib is under investigation in clinical trial NCT03898479 (Extension Study to Evaluate Safety and …
Timolol
Timolol is a nonselective beta-adrenergic antagonist given in an eye drop solution to reduce intraocular pressure, or pressure in the eyes. It is also used in tablet form as a drug to treat hypertension. Timolol was first approved by the FDA in 1978. This drug is marketed by several manufacturers...
Approved
Matched Description: … of conditions such as open-angle glaucoma and hypertension. ... [L6724] This drug is marketed by several manufacturers [L6736] and is an effective agent for the management ... Timolol is a nonselective beta-adrenergic antagonist given in an eye drop solution to reduce intraocular …
Matched Mixtures name: … Dorzolamide Hydrochloride and Timolol Maleate ... Dorzolamide HCl and Timolol Maleate ... Dorzolamide and Timolol …
Matched Categories: … Beta Blocking Agents and Thiazides ... Beta Blocking Agents, Non-Selective, and Thiazides ... Antiglaucoma Preparations and Miotics ... Adrenergic beta-Antagonists ... timolol and thiazides …
Matched Products: … Beta-tim - 0.5% Liq ... Beta-tim - 0.25% Liq …
Matched Mixtures name: … Dorzolamide Hydrochloride and Timolol Maleate ... Dorzolamide HCl and Timolol Maleate ... Dorzolamide and Timolol …
Matched Categories: … Beta Blocking Agents and Thiazides ... Beta Blocking Agents, Non-Selective, and Thiazides ... Antiglaucoma Preparations and Miotics ... Adrenergic beta-Antagonists ... timolol and thiazides …
Matched Products: … Beta-tim - 0.5% Liq ... Beta-tim - 0.25% Liq …
Mirtazapine
Mirtazapine is a tetracyclic piperazino-azepine antidepressant agent that was initially approved for the treatment of major depressive disorder (MDD) in the Netherlands in 1994. This drug was first manufactured by Organon Inc., and received FDA approval in 1997 for the treatment of major depressive disorder.[T595, L6157] The effects of this...
Approved
Matched Description: … prevent nausea and vomiting after surgery. ... ., and received FDA approval in 1997 for the treatment of major depressive disorder. ... symptoms of neurological disorders, reverse weight loss caused by medical conditions, improve sleep, and …
Matched Products: … MIRTAZAPIN BETA 15MG ... MIRTAZAPIN BETA 30MG ... MIRTAZAPIN BETA 45MG …
Matched Products: … MIRTAZAPIN BETA 15MG ... MIRTAZAPIN BETA 30MG ... MIRTAZAPIN BETA 45MG …
Ceramide NP
Ceramide NP is a lipid molecule included in a group of lipid molecules called ceramides. Ceramides are major lipid components in the stratum corneum of the human skin. Ceramide 3 consists of a phytosphingosine backbone N-acylated with a saturated fatty acid (stearic acid) . It is widely used as a...
Experimental
Matched Synonyms: … N-(9Z-octadecenoyl)phytosphingosine ... N-(9Z-octadecenoyl)-4-hydroxysphinganine …
Matched Iupac: … (9Z)-N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]octadec-9-enamide …
Matched Description: … It is widely used as a moisturizer in various cosmetic and personal products. …
Matched Iupac: … (9Z)-N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]octadec-9-enamide …
Matched Description: … It is widely used as a moisturizer in various cosmetic and personal products. …
Arachidonyltrifluoromethane
Specific inhibitor of phospholipase A2.
Investigational
Matched Synonyms: … 6,9,12,15-heneicosatetraen-2-one, 1,1,1-trifluoro-, (6z,9z,12z,15z)- …
Matched Iupac: … (6Z,9Z,12Z,15Z)-1,1,1-trifluorohenicosa-6,9,12,15-tetraen-2-one …
Matched Iupac: … (6Z,9Z,12Z,15Z)-1,1,1-trifluorohenicosa-6,9,12,15-tetraen-2-one …
beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide
Experimental
Matched Name: … beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide …
Ciprofloxacin
Ciprofloxacin is a second generation fluoroquinolone that has spawned many derivative antibiotics. It is formulated for oral, intravenous, intratympanic, ophthalmic, and otic administration for a number of bacterial infections.[L6469,L6472,L6475,L6478,L6481,L6484,L6487,L6490,L6493]
The first ciprofloxacin containing product was FDA approved on 22 October 1987.
Approved
Investigational
Matched Description: … [A178870] It is formulated for oral, intravenous, intratympanic, ophthalmic, and otic administration …
Matched Mixtures name: … Ciprofloxacin and Dexamethasone ... Ciprofloxacin and Dexamethasone ... Ciprofloxacin and Fluocinolone Acetonide …
Matched Categories: … ciprofloxacin and tinidazole ... ciprofloxacin and ornidazole ... ciprofloxacin and metronidazole ... Drug-Related Side Effects and Adverse Reactions ... Ophthalmological and Otological Preparations …
Matched Products: … Ciprofloxacin and Dextrose ... CILOXAN STERILE OPHTHALMIC AND OTIC SOLUTION 0.3% …
Matched Mixtures name: … Ciprofloxacin and Dexamethasone ... Ciprofloxacin and Dexamethasone ... Ciprofloxacin and Fluocinolone Acetonide …
Matched Categories: … ciprofloxacin and tinidazole ... ciprofloxacin and ornidazole ... ciprofloxacin and metronidazole ... Drug-Related Side Effects and Adverse Reactions ... Ophthalmological and Otological Preparations …
Matched Products: … Ciprofloxacin and Dextrose ... CILOXAN STERILE OPHTHALMIC AND OTIC SOLUTION 0.3% …
Arabinouridine 3'-phosphate
Experimental
Matched Synonyms: … 1-(3-O-phosphono-beta-L-arabinofuranosyl)Pyrimidine-2,4(1H,3H)-Dione …
Mizagliflozin
Mizagliflozin is under investigation in clinical trial NCT05721729 (Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions).
Investigational
Matched Synonyms: … 3-((3-(4-((3-(.beta. ... Propanamide, 3-((3-(4-((3-(.beta. …
Matched Description: … investigation in clinical trial NCT05721729 (Effect of Mizagliflozin Repeat Dosing on Adverse Events and …
Matched Description: … investigation in clinical trial NCT05721729 (Effect of Mizagliflozin Repeat Dosing on Adverse Events and …
Displaying drugs 651 - 675 of 908 in total